Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Big Biotech M&A Targets: Who Could Follow Astellas' $3.5B Bid for OSI?
Big Biotech M&A Targets: Who Could Follow Astellas' $3.5B Bid for OSI?
Big Biotech M&A Targets: Who Could Follow Astellas' $3.5B Bid for OSI?
Submitted by
admin
on March 9, 2010 - 11:28am
Source:
BNET Pharma
News Tags:
M&A
Astellas
OSI Pharmaceuticals
Vertex Pharmaceuticals
Human Genome Sciences
Alexion
United Therapeutics
ONYX Pharmaceuticals
Allos
Auxilium
Headline:
Big Biotech M&A Targets: Who Could Follow Astellas' $3.5B Bid for OSI?
Do Not Allow Advertisers to Use My Personal information
